Tingting Xu

Dr. Tingting Xu

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2010 in Sensors
Verified
Journal Article
Open access
PDF file
DCDan Close
Dan Close
TXTingting Xu
Tingting Xu
GSGary S. Sayler
Gary S. Sayler
SRSteven Ripp
Steven Ripp
In vivo bioluminescent imaging (BLI) is increasingly being utilized as a method for modern biological research. This process, which involves the noninvasive interrogation of living animals using light emitted from luciferase-expressing bioreporter cells, has been applied to study a wide range of biomolecular functions such as gene function, drug discovery and development, cellular trafficking, protein-protein interactions, and especially tumorigenesis, cancer treatment, and disease progression. This article will review the various bioreporter/biosensor integrations of BLI and discuss how BLI is being applied towards a new visual understanding of biological processes within the living organism.

11 January 2012 in Sensors
Verified
Journal Article
Open access
PDF file
DCDan Close
Dan Close
TXTingting Xu
Tingting Xu
ASAbby Smartt
Abby Smartt
ARAlexandra Rogers
Alexandra Rogers
RCRobert Crossley
Robert Crossley
GSGary Sayler
Gary Sayler
The bacterial luciferase gene cassette (lux) is unique among bioluminescent bioreporter systems due to its ability to synthesize and/or scavenge all of the substrate compounds required for its production of light. As a result, the lux system has the unique ability to autonomously produce a luminescent signal, either continuously or in response to the presence of a specific trigger, across a wide array of organismal hosts. While originally employed extensively as a bacterial bioreporter system for the detection of specific chemical signals in environmental samples, the use of lux as a bioreporter technology has continuously expanded over the last 30 years to include expression in eukaryotic cells such as Saccharomyces cerevisiae and even human cell lines as well. Under these conditions, the lux system has been developed for use as a biomedical detection tool for toxicity screening and visualization of tumors in small animal models. As the technologies for lux signal detection continue to improve, it is poised to become one of the first fully implantable detection systems for intra-organismal optical detection through direct marriage to an implantable photon-detecting digital chip. This review presents the basic biochemical background that allows the lux system to continuously autobioluminesce and highlights the important milestones in the use of lux-based bioreporters as they have evolved from chemical detection platforms in prokaryotic bacteria to rodent-based tumorigenesis study targets. In addition, the future of lux imaging using integrated circuit microluminometry to image directly within a living host in real-time will be introduced and its role in the development of dose/response therapeutic systems will be highlighted.

5 August 2021 in BioTechniques
Verified
Journal Article
Open access
TXTingting Xu
Tingting Xu
MGMadison Gilliam
Madison Gilliam
GSGary Sayler
Gary Sayler
SRSteven Ripp
Steven Ripp
DCDan Close
Dan Close
Due to the public health concerns of endocrine-disrupting chemicals, there is an increasing demand to develop improved high-throughput detection assays for enhanced exposure control and risk assess... METHOD SUMMARY A human optimized version of the bacterial luciferase gene cassette was developed such that bioluminescence is controlled by exposure to androgen-disruptor chemicals. This cassette, ...

25 September 2019
Verified
Book Chapter
Open access
PDF file
AKAndrew Kirkpatrick
Andrew Kirkpatrick
TXTingting Xu
Tingting Xu
SRSteven Ripp
Steven Ripp
GSGary Sayler
Gary Sayler
DCDan Close
Dan Close
This chapter explores the history of the bioengineering advances that have been applied to common luciferase enzymes and the improvements that have been accomplished by this work. The primary focus is placed on firefly luciferase (FLuc), Gaussia luciferase (GLuc), Renilla luciferase (RLuc), Oplophorus luciferase (OLuc; NanoLuc), and bacterial luciferase (Lux). Beginning with the cloning and exogenous expression of each enzyme, their step-wise modifications are presented and the new capabilities endowed by each incremental advancement are highlighted. Using the historical basis of this information, the chapter concludes with a prospective on the overall impact these advances have had on scientific research and provides an outlook on what capabilities future advances could unlock.

13 November 2019
Verified
Book Chapter
Closed access
PDF file
TXTingting Xu
Tingting Xu
AYAnna Young
Anna Young
JNJasleen Narula
Jasleen Narula
GSGary Sayler
Gary Sayler
SRSteven Ripp
Steven Ripp

6 December 2017 in Sensors
Verified
Journal Article
Open access
PDF file
TXTingting Xu
Tingting Xu
MCMichael Conway
Michael Conway
AFAshley Frank
Ashley Frank
SRSteven Ripp
Steven Ripp
GSGary Sayler
Gary Sayler
DCDan Close
Dan Close
Modern drug discovery workflows require assay systems capable of replicating the complex interactions of multiple tissue types, but that can still function under high throughput conditions. In this work, we evaluate the use of substrate-free autobioluminescence in human cell lines to support the performance of these assays with reduced economical and logistical restrictions relative to substrate-requiring bioluminescent reporter systems. The use of autobioluminescence was found to support assay functionality similar to existing luciferase reporter targets. The autobioluminescent assay format was observed to correlate strongly with general metabolic activity markers such as ATP content and the presence of reactive oxygen species, but not with secondary markers such as glutathione depletion. At the transcriptional level, autobioluminescent dynamics were most closely associated with expression of the CYP1A1 phase I detoxification pathway. These results suggest constitutively autobioluminescent cells can function as general metabolic activity bioreporters, while pairing expression of the autobioluminescent phenotype to detoxification pathway specific promoters could create more specific sensor systems.